These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19119477)

  • 1. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Int J Colorectal Dis; 2009 Mar; 24(3):261-8. PubMed ID: 19119477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative RT-PCR detection of tumor cells in sentinel lymph nodes isolated from colon cancer patients with an ex vivo approach.
    Nordgård O; Oltedal S; Kørner H; Aasprong OG; Tjensvoll K; Gilje B; Heikkilä R
    Ann Surg; 2009 Apr; 249(4):602-7. PubMed ID: 19300229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.
    Nordgård O; Oltedal S; Aasprong OG; Søreide JA; Søreide K; Tjensvoll K; Gilje B; Heikkilä R; Guriby M; Lothe RA; Smaaland R; Kørner H
    Ann Surg Oncol; 2012 Nov; 19(12):3719-26. PubMed ID: 22752373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay.
    Lotspeich E; Schoene M; Gerngross H; Schmidt R; Steinmann R; Ramadani M; Gansauge S
    Langenbecks Arch Surg; 2007 Sep; 392(5):559-66. PubMed ID: 17457603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
    Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
    Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of occult metastases in colon cancer.
    Merrie AE; van Rij AM; Dennett ER; Phillips LV; Yun K; McCall JL
    Dis Colon Rectum; 2003 Feb; 46(2):221-31. PubMed ID: 12576896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 20 and guanylyl cyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients.
    Conzelmann M; Dieterle CP; Linnemann U; Berger MR
    Int J Cancer; 2003 Nov; 107(4):617-28. PubMed ID: 14520701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.
    D'Armento G; Daniele L; Mariani S; Ottaviani D; Mussa A; Cassoni P; Sapino A; Bussolati G
    Int J Surg Pathol; 2009 Apr; 17(2):93-8. PubMed ID: 19074466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
    Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
    Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
    Ichikawa Y; Ishikawa T; Momiyama N; Yamaguchi S; Masui H; Hasegawa S; Chishima T; Takimoto A; Kitamura H; Akitaya T; Hosokawa T; Mitsuhashi M; Shimada H
    Clin Exp Metastasis; 1998 Jan; 16(1):3-8. PubMed ID: 9502072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
    Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
    Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of micrometastases in the lymph nodes of gastric cancer patients with real-time RT-PCR: a comparative study with immunohistochemistry.
    Kubota K; Nakanishi H; Hiki N; Shimizu N; Tsuji E; Yamaguchi H; Mafune K; Tange T; Tatematsu M; Kaminishi M
    Int J Cancer; 2003 May; 105(1):136-43. PubMed ID: 12672044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR.
    Weber T; Lacroix J; Wörner S; Weckauf H; Winkler S; Hinz U; Schilling T; Frank-Raue K; Klar E; Knebel Doeberitz Mv Mv
    Int J Cancer; 2003 Jan; 103(1):126-31. PubMed ID: 12455065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
    Olsson L; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2020 Jun; 42(6):1010428320924524. PubMed ID: 32515296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes.
    Bernini A; Spencer M; Frizelle S; Madoff RD; Willmott LD; McCormick SR; Niehans GA; Ho SB; Kratzke RA
    Cancer Detect Prev; 2000; 24(1):72-9. PubMed ID: 10757125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of lymph node micrometastasis in gastric cancer by MUC2 RT-PCR: usefulness in pT1 cases.
    Sonoda H; Yamamoto K; Kushima R; Okabe H; Tani T
    J Surg Oncol; 2004 Nov; 88(2):63-70. PubMed ID: 15499573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
    Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
    J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.